Health CanadaType II
MAR-Cetirizine 20 mg tablet: Out of specification (Impurities)
Published: March 20, 2025Recall ID: 77145Category: generalCountry: Canada
Reason for Recall / Hazard
Product quality
Product Description & Identification
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
MAR-Cetirizine 20 mg tablet
Additional Source Details
| Field | Value |
|---|---|
| N I D | 77145 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/mar-cetirizine-20-mg-tablet-out-specification-impurities |
| Issue | Product quality |
| Title | MAR-Cetirizine 20 mg tablet: Out of specification (Impurities) |
| Product | MAR-Cetirizine 20 mg tablet |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2025-03-20 |
| Organization | Drugs and health products |
| Recall class | Type II |
| What you should do | Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |